Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,864,602−100.0%Sold outHolders
Q1 20261,864,602$27.0M<0.1%−387,108−17.2%ReducedHolders
Q4 20252,251,710$32.1M<0.1%+434,700+23.9%AddedHolders
Q3 20251,817,010$14.3M<0.1%+566,641+45.3%AddedHolders
Q2 20251,250,369$7.16M<0.1%+747,461+148.6%AddedHolders
Q1 2025502,908$4.10M<0.1%+18,348+3.8%AddedHolders
Q4 2024484,560$4.56M<0.1%−81,416−14.4%ReducedHolders
Q3 2024565,976$6.04M<0.1%+225,222+66.1%AddedHolders
Q2 2024340,754$3.38M<0.1%−247,881−42.1%ReducedHolders
Q1 2024588,635$6.93M<0.1%−334,410−36.2%ReducedHolders
Q4 2023923,045$13.1M<0.1%+536,480+138.8%AddedHolders
Q3 2023386,565$4.70M<0.1%+224,870+139.1%AddedHolders
Q2 2023161,695$2.03M<0.1%−122,086−43.0%ReducedHolders
Q1 2023283,781$3.15M<0.1%+142,974+101.5%AddedHolders
Q4 2022140,807$1.72M<0.1%−210,939−60.0%ReducedHolders
Q3 2022351,746$3.67M<0.1%+8,094+2.4%AddedHolders
Q2 2022343,652$3.69M<0.1%−217,922−38.8%ReducedHolders
Q1 2022561,574$5.32M<0.1%−69,751−11.0%ReducedHolders
Q4 2021631,325$7.29M<0.1%+45,272+7.7%AddedHolders
Q3 2021586,053$5.60M<0.1%−168,988−22.4%ReducedHolders
Q2 2021755,041$7.28M<0.1%−24,282−3.1%ReducedHolders
Q1 2021779,323$7.70M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.